Clinical trial
An Open-Label, MultiCenter Evaluation of the Use of Topically Administered FP1198 in Subjects With Pain Associated With Cyclic Mastalgia
NCT01105793 is registered in ClinicalTrials.gov with FemmePharma Global Healthcare, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label, MultiCenter Evaluation of the Use of Topically Administered FP1198 in Subjects With Pain Associated With Cyclic Mastalgia
- Lead sponsor
- FemmePharma Global Healthcare, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 30, 2010
- Completion date
- June 30, 2011
- Enrollment
- 20 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
moderate to severe cyclic mastalgia